Herpes Simplex Labialis
1000 mg PO qD-TID x 6-12 months
Topical: (Super Lysine Plus) applied q2hr x11days
10 g PO qDay divided doses for up to 5 days
Athletic performance enhancement, herpes simplex labialis, metabolic alkalosis
Possibly effective for herpes simplex labialis treatment
Diarrhea, abdominal pain, chronic renal failure, interstitial nephritis
Pregnancy & Lactation
Pregnancy Category: avoid use
Lactation: avoid use
A:Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B:May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
C:Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
D:Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
X:Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.
NA:Information not available.
Mechanism of Action
Lysine inhibits replication of arginine-rich herpes viruses